Legis Daily

Federal Kratom Consumer Protection Act

USA118th CongressHR-5905| House 
| Updated: 10/25/2023
Mark Pocan

Mark Pocan

Democratic Representative

Wisconsin

Cosponsors (1)
Jack Bergman (Republican)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Federal Kratom Consumer Protection Act This bill requires the Food and Drug Administration (FDA) to hold a hearing and establish a task force on the health and safety of products with kratom (an herbal substance that produces opioid- and stimulant-like effects). It also prohibits the FDA from regulating kratom products in a manner that is more restrictive as compared to regulations for food, dietary supplements, or dietary ingredients.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 4, 2023

Latest Companion Bill Action

S 118-3039
Introduced in Senate
Oct 6, 2023
Introduced in House
Oct 25, 2023
Referred to the House Committee on Energy and Commerce.
Oct 25, 2023
Referred to the Subcommittee on Health.
  • October 4, 2023

    Latest Companion Bill Action

    S 118-3039
    Introduced in Senate


  • October 6, 2023
    Introduced in House


  • October 25, 2023
    Referred to the House Committee on Energy and Commerce.


  • October 25, 2023
    Referred to the Subcommittee on Health.

Health

Related Bills

  • S 118-3039: Federal Kratom Consumer Protection Act
Administrative law and regulatory proceduresAdvisory bodiesCongressional oversightConsumer affairsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationExecutive agency funding and structureFood and Drug Administration (FDA)Food supply, safety, and labelingGovernment information and archivesResearch administration and funding

Federal Kratom Consumer Protection Act

USA118th CongressHR-5905| House 
| Updated: 10/25/2023
Federal Kratom Consumer Protection Act This bill requires the Food and Drug Administration (FDA) to hold a hearing and establish a task force on the health and safety of products with kratom (an herbal substance that produces opioid- and stimulant-like effects). It also prohibits the FDA from regulating kratom products in a manner that is more restrictive as compared to regulations for food, dietary supplements, or dietary ingredients.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 4, 2023

Latest Companion Bill Action

S 118-3039
Introduced in Senate
Oct 6, 2023
Introduced in House
Oct 25, 2023
Referred to the House Committee on Energy and Commerce.
Oct 25, 2023
Referred to the Subcommittee on Health.
  • October 4, 2023

    Latest Companion Bill Action

    S 118-3039
    Introduced in Senate


  • October 6, 2023
    Introduced in House


  • October 25, 2023
    Referred to the House Committee on Energy and Commerce.


  • October 25, 2023
    Referred to the Subcommittee on Health.
Mark Pocan

Mark Pocan

Democratic Representative

Wisconsin

Cosponsors (1)
Jack Bergman (Republican)

Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 118-3039: Federal Kratom Consumer Protection Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresAdvisory bodiesCongressional oversightConsumer affairsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationExecutive agency funding and structureFood and Drug Administration (FDA)Food supply, safety, and labelingGovernment information and archivesResearch administration and funding